Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Donato

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|July 25, 2024
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 VaccineLetizia Corinna Morlacchi, Gianfranco Alicandro, Sara Uceda Renteria, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2017
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experienceSilvia Martini, Maria Francesca Donato, Chiara Mazzarelli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 14, 2015
Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantationAlessandro Vitale, Gaya Spolverato, Patrizia Burra, et al.
Frontiers in Oncology|May 1, 2020
Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter ExperienceFederica Invenizzi, Massimo Iavarone, Maria Francesca Donato, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 13, 2012
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsersFrancesca Romana Ponziani, Alessandro Milani, Antonio Gasbarrini, et al.
Biomedicines|August 26, 2022
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort StudySimona Biscarini, Simone Villa, Camilla Genovese, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 16, 2017
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN studyXavier Forns, Marina Berenguer, Kerstin Herzer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 22, 2023
Perfusion fluid-related infections in liver transplant recipients: A 5-year, single-center, retrospective studyAndrea Lombardi, Giulia Renisi, Daniele Dondossola, et al.
Journal of Hepatology|May 24, 2016
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European studyLuca Saverio Belli, Marina Berenguer, Paolo Angelo Cortesi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2013
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis CDavide Bitetto, Tullia De Feo, Martina Mantovani, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Transplant International : Official Journal of the European Society for Organ Transplantation|July 25, 2024
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 VaccineLetizia Corinna Morlacchi, Gianfranco Alicandro, Sara Uceda Renteria, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2017
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experienceSilvia Martini, Maria Francesca Donato, Chiara Mazzarelli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 14, 2015
Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantationAlessandro Vitale, Gaya Spolverato, Patrizia Burra, et al.
Frontiers in Oncology|May 1, 2020
Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter ExperienceFederica Invenizzi, Massimo Iavarone, Maria Francesca Donato, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 13, 2012
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsersFrancesca Romana Ponziani, Alessandro Milani, Antonio Gasbarrini, et al.
Biomedicines|August 26, 2022
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort StudySimona Biscarini, Simone Villa, Camilla Genovese, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 16, 2017
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN studyXavier Forns, Marina Berenguer, Kerstin Herzer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 22, 2023
Perfusion fluid-related infections in liver transplant recipients: A 5-year, single-center, retrospective studyAndrea Lombardi, Giulia Renisi, Daniele Dondossola, et al.
Journal of Hepatology|May 24, 2016
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European studyLuca Saverio Belli, Marina Berenguer, Paolo Angelo Cortesi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2013
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis CDavide Bitetto, Tullia De Feo, Martina Mantovani, et al.
Pageof 9